Abou-Ismail, M. Y., Arafah, Y., Fu, P., Cao, S., Schmaier, A. H., & Nayak, L. (2020). Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab. Front Med (Lausanne).
Citação norma ChicagoAbou-Ismail, Mouhamed Yazan, Yasmin Arafah, Pingfu Fu, Shufen Cao, Alvin H. Schmaier, and Lalitha Nayak. "Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide Vs. Rituximab." Front Med (Lausanne) 2020.
Deismireacht MLAAbou-Ismail, Mouhamed Yazan, et al. "Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide Vs. Rituximab." Front Med (Lausanne) 2020.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.